ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY GERALYN FRANDSEN &
SANDRA PENNINGTON ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY
GERALYN FRANDSEN & SANDRA PENNINGTON
TEST BANK
ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH
EDITION BY GERALYN FRANDSEN & SANDRA PENNINGTON COMPLETE CHAPTER
GUIDE 1-61 WITH RATIONALES| A+ PASS
1|P age
,ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY GERALYN FRANDSEN &
SANDRA PENNINGTON ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY
GERALYN FRANDSEN & SANDRA PENNINGTON
Table of Content SECTION 1
The Conceptual Framework of Pharmacology Chapter 1 The Foundation of
Pharmacology: Quality and Safety Chapter 2 Basic Concepts and Processes
Chapter 3 Medication Administration and the Nursing Process of Drug Therapy
SECTION 2 Drug Therapy Throughout the Lifespan
Chapter 4 Pharmacology and the Care of Infants and Pediatric Patients Medication Administration in Pediatrics
Chapter 5 Pharmacology and the Care of Adults and Geriatric Patients Chapter 6
Pharmacology and the Care of Pregnant or Lactating Woman Chapter 7
Pharmacology and Women‘s Health
Chapter 8 Pharmacology and Men‘s Health
SECTION 3 Drugs Affecting the Hematopoietic and Immune Systems
Chapter 9 Drug Therapy for Coagulation Disorders Chapter
10 Drug Therapy for Dyslipidemia
Chapter 11 Drug Therapy for Hematopoietic Disorders
Chapter 12 Drug Therapy: Immunizations
Chapter 13 Drug Therapy to Decrease Immunity Chapter 14
Drug Therapy for the Treatment of Cancer
SECTION 4 Drugs Affecting Inflammation and Infection
Chapter 15 Inflammation, Infection, and the Use of Antimicrobial Agents Chapter
16 Drug Therapy to Decrease Pain, Fever, and Inflammation Chapter 17 Drug
Therapy With Corticosteroids
Chapter 18 Drug Therapy With Beta-Lactam Antibacterial Agents Chapter 19
Drug Therapy With Aminoglycosides and Fluoroquinolones
Chapter 20 Drug Therapy With Tetracyclines, Sulfonamides, and Urinary Antiseptics Chapter 21
Drug Therapy With Macrolides and Miscellaneous Anti-infective Agents Chapter 22 Drug Therapy
for Tuberculosis and Mycobacterium avium Complex Disease Chapter 23 Drug Therapy for Viral
Infections
Chapter 24 Drug Therapy for Fungal Infections Chapter 25
Drug Therapy for Parasitic Infections
2|P age
,ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY GERALYN FRANDSEN &
SANDRA PENNINGTON ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY
GERALYN FRANDSEN & SANDRA PENNINGTON
SECTION 5 Drugs Affecting the Cardiovascular System
Chapter 26 Drug Therapy for Hypertension Chapter
27 Drug Therapy for Dysrhythmias
Chapter 28 Drug Therapy for Coronary Heart Disease
Chapter 29 Drug Therapy for Shock and Hypotension
Chapter 30 Drug Therapy for Heart Failure
SECTION 6 Drugs Affecting the Respiratory System
Chapter 31 Drug Therapy for Nasal Congestion and Cough
Chapter 32 Drug Therapy to Decrease Histamine Effects and Allergic Response Chapter 33
Drug Therapy for Asthma and Bronchoconstriction
SECTION 7 Drugs Affecting the Renal and Digestive Systems
Chapter 34 Drug Therapy for Fluid Volume Excess
Chapter 35 Nutritional Support Products, Vitamins, and Mineral Supplements Chapter 36
Drug Therapy for Weight Management
Chapter 37 Drug Therapy for Peptic Ulcer Disease and Hyperacidity Chapter
38 Drug Therapy for Nausea and Vomiting
Chapter 39 Drug Therapy for Constipation and Elimination Problems Chapter
40 Drug Therapy for Diarrhea
SECTION 8 Drugs Affecting the Endocrine System Chapter 41
Drug Therapy for Diabetes Mellitus
Chapter 42 Drug Therapy for Hyperthyroidism and Hypothyroidism Chapter 43
Drug Therapy for Pituitary and Hypothalamic Dysfunction Chapter 44 Drug
Therapy to Regulate Calcium and Bone Metabolism Chapter 45 Drug Therapy for
Addison‘s Disease and Cushing‘s Disease Section 9 Drugs Affecting the Autonomic
and Central Nervous System
Chapter 46 Physiology of the Autonomic and Central Nervous Systems and Indications for the Use of Drug Therapy
3|P age
, ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY GERALYN FRANDSEN &
SANDRA PENNINGTON ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY
GERALYN FRANDSEN & SANDRA PENNINGTON
Chapter 47 Drug Therapy for Myasthenia Gravis, Alzheimer‘s Disease, and Urinary Retention
Chapter 48 Drug Therapy for Parkinson‘s Disease, Urinary Spasticity, and Disorders Requiring
Anticholinergic Drug Therapy
Chapter 49 Drug Therapy With Opioids
Chapter 50 Drug Therapy With Local Anesthetics
Chapter 51 Drug Therapy With General Anesthetics
Chapter 52 Drug Therapy for Migraines and Other Headaches
Chapter 53 Drug Therapy for Seizure Disorders and Spasticity
Chapter 54 Drug Therapy for Anxiety and Insomnia
Chapter 55 Drug Therapy for Depression and Mood Stabilization Chapter 56
Drug Therapy for Psychotic Disorders
Chapter 57 Drug Therapy for Attention Deficit Hyperactivity Disorder and Narcolepsy Chapter 58
Drug Therapy for Substance Abuse Disorders
Section 10 Drugs Affecting the Eye, Ear, and Skin Chapter 59
Drug Therapy for Disorders of the Eye Chapter 60 Drug
Therapy for Disorders of the Ear Chapter 61 Drug Therapy
for Disorders of the Skin
Chapter 1 : The Foundation of Pharmacology: Quality and Safety :
1. A woman diagnosed with obsessive–compulsive disorder has been prescribed oral
paroxetine hydrochloride. What is the expected effect for this prescription?
A. Curative effect on symptoms
B. Systemic effect on symptoms
C. Local effect on symptoms
D. Parenteral effect on
symptoms ANS >> B
Rationale: Drugs that produce systemic effects are taken into the body, circulated through the
bloodstream to their sites of action in various body tissues, and eventually eliminated from the
body. Curative agents are given to cure a disease process. In this case, paroxetine hydrochloride
4|P age
SANDRA PENNINGTON ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY
GERALYN FRANDSEN & SANDRA PENNINGTON
TEST BANK
ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH
EDITION BY GERALYN FRANDSEN & SANDRA PENNINGTON COMPLETE CHAPTER
GUIDE 1-61 WITH RATIONALES| A+ PASS
1|P age
,ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY GERALYN FRANDSEN &
SANDRA PENNINGTON ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY
GERALYN FRANDSEN & SANDRA PENNINGTON
Table of Content SECTION 1
The Conceptual Framework of Pharmacology Chapter 1 The Foundation of
Pharmacology: Quality and Safety Chapter 2 Basic Concepts and Processes
Chapter 3 Medication Administration and the Nursing Process of Drug Therapy
SECTION 2 Drug Therapy Throughout the Lifespan
Chapter 4 Pharmacology and the Care of Infants and Pediatric Patients Medication Administration in Pediatrics
Chapter 5 Pharmacology and the Care of Adults and Geriatric Patients Chapter 6
Pharmacology and the Care of Pregnant or Lactating Woman Chapter 7
Pharmacology and Women‘s Health
Chapter 8 Pharmacology and Men‘s Health
SECTION 3 Drugs Affecting the Hematopoietic and Immune Systems
Chapter 9 Drug Therapy for Coagulation Disorders Chapter
10 Drug Therapy for Dyslipidemia
Chapter 11 Drug Therapy for Hematopoietic Disorders
Chapter 12 Drug Therapy: Immunizations
Chapter 13 Drug Therapy to Decrease Immunity Chapter 14
Drug Therapy for the Treatment of Cancer
SECTION 4 Drugs Affecting Inflammation and Infection
Chapter 15 Inflammation, Infection, and the Use of Antimicrobial Agents Chapter
16 Drug Therapy to Decrease Pain, Fever, and Inflammation Chapter 17 Drug
Therapy With Corticosteroids
Chapter 18 Drug Therapy With Beta-Lactam Antibacterial Agents Chapter 19
Drug Therapy With Aminoglycosides and Fluoroquinolones
Chapter 20 Drug Therapy With Tetracyclines, Sulfonamides, and Urinary Antiseptics Chapter 21
Drug Therapy With Macrolides and Miscellaneous Anti-infective Agents Chapter 22 Drug Therapy
for Tuberculosis and Mycobacterium avium Complex Disease Chapter 23 Drug Therapy for Viral
Infections
Chapter 24 Drug Therapy for Fungal Infections Chapter 25
Drug Therapy for Parasitic Infections
2|P age
,ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY GERALYN FRANDSEN &
SANDRA PENNINGTON ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY
GERALYN FRANDSEN & SANDRA PENNINGTON
SECTION 5 Drugs Affecting the Cardiovascular System
Chapter 26 Drug Therapy for Hypertension Chapter
27 Drug Therapy for Dysrhythmias
Chapter 28 Drug Therapy for Coronary Heart Disease
Chapter 29 Drug Therapy for Shock and Hypotension
Chapter 30 Drug Therapy for Heart Failure
SECTION 6 Drugs Affecting the Respiratory System
Chapter 31 Drug Therapy for Nasal Congestion and Cough
Chapter 32 Drug Therapy to Decrease Histamine Effects and Allergic Response Chapter 33
Drug Therapy for Asthma and Bronchoconstriction
SECTION 7 Drugs Affecting the Renal and Digestive Systems
Chapter 34 Drug Therapy for Fluid Volume Excess
Chapter 35 Nutritional Support Products, Vitamins, and Mineral Supplements Chapter 36
Drug Therapy for Weight Management
Chapter 37 Drug Therapy for Peptic Ulcer Disease and Hyperacidity Chapter
38 Drug Therapy for Nausea and Vomiting
Chapter 39 Drug Therapy for Constipation and Elimination Problems Chapter
40 Drug Therapy for Diarrhea
SECTION 8 Drugs Affecting the Endocrine System Chapter 41
Drug Therapy for Diabetes Mellitus
Chapter 42 Drug Therapy for Hyperthyroidism and Hypothyroidism Chapter 43
Drug Therapy for Pituitary and Hypothalamic Dysfunction Chapter 44 Drug
Therapy to Regulate Calcium and Bone Metabolism Chapter 45 Drug Therapy for
Addison‘s Disease and Cushing‘s Disease Section 9 Drugs Affecting the Autonomic
and Central Nervous System
Chapter 46 Physiology of the Autonomic and Central Nervous Systems and Indications for the Use of Drug Therapy
3|P age
, ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY GERALYN FRANDSEN &
SANDRA PENNINGTON ABRAMS' CLINICAL DRUG THERAPY: RATIONALES FOR NURSING PRACTICE 13TH EDITION BY
GERALYN FRANDSEN & SANDRA PENNINGTON
Chapter 47 Drug Therapy for Myasthenia Gravis, Alzheimer‘s Disease, and Urinary Retention
Chapter 48 Drug Therapy for Parkinson‘s Disease, Urinary Spasticity, and Disorders Requiring
Anticholinergic Drug Therapy
Chapter 49 Drug Therapy With Opioids
Chapter 50 Drug Therapy With Local Anesthetics
Chapter 51 Drug Therapy With General Anesthetics
Chapter 52 Drug Therapy for Migraines and Other Headaches
Chapter 53 Drug Therapy for Seizure Disorders and Spasticity
Chapter 54 Drug Therapy for Anxiety and Insomnia
Chapter 55 Drug Therapy for Depression and Mood Stabilization Chapter 56
Drug Therapy for Psychotic Disorders
Chapter 57 Drug Therapy for Attention Deficit Hyperactivity Disorder and Narcolepsy Chapter 58
Drug Therapy for Substance Abuse Disorders
Section 10 Drugs Affecting the Eye, Ear, and Skin Chapter 59
Drug Therapy for Disorders of the Eye Chapter 60 Drug
Therapy for Disorders of the Ear Chapter 61 Drug Therapy
for Disorders of the Skin
Chapter 1 : The Foundation of Pharmacology: Quality and Safety :
1. A woman diagnosed with obsessive–compulsive disorder has been prescribed oral
paroxetine hydrochloride. What is the expected effect for this prescription?
A. Curative effect on symptoms
B. Systemic effect on symptoms
C. Local effect on symptoms
D. Parenteral effect on
symptoms ANS >> B
Rationale: Drugs that produce systemic effects are taken into the body, circulated through the
bloodstream to their sites of action in various body tissues, and eventually eliminated from the
body. Curative agents are given to cure a disease process. In this case, paroxetine hydrochloride
4|P age
